CME Group Inc. (NASDAQ:CME) Stock Position Raised by Janus Henderson Group PLC

Janus Henderson Group PLC boosted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 24.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,135,753 shares of the financial services provider's stock after purchasing an additional 621,713 shares during the period. Janus Henderson Group PLC owned 0.87% of CME Group worth $728,260,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CME. JARISLOWSKY FRASER Ltd lifted its position in shares of CME Group by 0.8% in the fourth quarter. JARISLOWSKY FRASER Ltd now owns 223,879 shares of the financial services provider's stock worth $51,991,000 after purchasing an additional 1,819 shares in the last quarter. KKM Financial LLC lifted its position in CME Group by 5.2% in the 4th quarter. KKM Financial LLC now owns 11,179 shares of the financial services provider's stock worth $2,596,000 after buying an additional 549 shares in the last quarter. Guardian Wealth Advisors LLC NC boosted its stake in shares of CME Group by 7.3% during the 4th quarter. Guardian Wealth Advisors LLC NC now owns 1,294 shares of the financial services provider's stock valued at $301,000 after buying an additional 88 shares during the period. Gotham Asset Management LLC grew its holdings in shares of CME Group by 9.2% during the 4th quarter. Gotham Asset Management LLC now owns 85,977 shares of the financial services provider's stock valued at $19,966,000 after acquiring an additional 7,209 shares in the last quarter. Finally, Focus Partners Wealth increased its stake in shares of CME Group by 12.9% in the fourth quarter. Focus Partners Wealth now owns 165,834 shares of the financial services provider's stock worth $38,583,000 after acquiring an additional 19,007 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CME Group

In other news, Director Dennis Suskind sold 1,000 shares of the stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the transaction, the director now owns 2,915 shares in the company, valued at approximately $790,781.20. This represents a 25.54 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Derek Sammann sold 4,650 shares of CME Group stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the sale, the insider now owns 8,336 shares in the company, valued at approximately $2,339,164.96. This trade represents a 35.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 34,726 shares of company stock worth $8,975,813. Company insiders own 0.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Oppenheimer lifted their price objective on CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research report on Friday, April 11th. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target for the company in a research note on Monday, March 10th. Keefe, Bruyette & Woods increased their price objective on CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. Piper Sandler boosted their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Finally, UBS Group raised their price target on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a report on Friday, April 25th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, CME Group has a consensus rating of "Hold" and an average target price of $256.80.

CME Group Stock Performance

CME opened at $284.35 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock's 50 day moving average price is $264.47 and its two-hundred day moving average price is $245.67. The firm has a market capitalization of $102.47 billion, a P/E ratio of 29.41, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $286.48.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. CME Group's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the company posted $2.50 earnings per share. On average, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio is currently 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.